- Home
- ACHC vs LNTH Comparison
ACHC vs LNTH Comparison
Compare ACHC & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHC
- LNTH
- Stock Information
- Founded
- ACHC 2005
- LNTH 1956
- Country
- ACHC United States
- LNTH United States
- Employees
- ACHC N/A
- LNTH N/A
- Industry
- ACHC Medical Specialities
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ACHC Health Care
- LNTH Health Care
- Exchange
- ACHC Nasdaq
- LNTH Nasdaq
- Market Cap
- ACHC 2.1B
- LNTH 7.5B
- IPO Year
- ACHC N/A
- LNTH 2015
- Fundamental
- Price
- ACHC $25.72
- LNTH $78.81
- Analyst Decision
- ACHC Strong Buy
- LNTH Strong Buy
- Analyst Count
- ACHC 10
- LNTH 5
- Target Price
- ACHC $52.25
- LNTH $133.80
- AVG Volume (30 Days)
- ACHC 3.6M
- LNTH 1.3M
- Earning Date
- ACHC 05-12-2025
- LNTH 05-07-2025
- Dividend Yield
- ACHC N/A
- LNTH N/A
- EPS Growth
- ACHC N/A
- LNTH N/A
- EPS
- ACHC 2.04
- LNTH 3.53
- Revenue
- ACHC $3,156,417,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- ACHC $7.90
- LNTH $5.81
- Revenue Next Year
- ACHC $8.58
- LNTH $12.26
- P/E Ratio
- ACHC $12.60
- LNTH $22.33
- Revenue Growth
- ACHC 5.48
- LNTH 12.53
- 52 Week Low
- ACHC $20.36
- LNTH $74.34
- 52 Week High
- ACHC $82.41
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- ACHC 53.03
- LNTH 27.83
- Support Level
- ACHC $23.83
- LNTH $78.61
- Resistance Level
- ACHC $28.48
- LNTH $83.60
- Average True Range (ATR)
- ACHC 1.29
- LNTH 3.82
- MACD
- ACHC 0.71
- LNTH -2.99
- Stochastic Oscillator
- ACHC 61.56
- LNTH 5.64
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.